Erica Pietroluongo
Overview
Explore the profile of Erica Pietroluongo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peddio A, Pietroluongo E, Lamia M, Luciano A, Caltavituro A, Buonaiuto R, et al.
Crit Rev Oncol Hematol
. 2024 Sep;
204:104524.
PMID: 39326646
Neuroendocrine neoplasms (NENs) represent a diagnostic and therapeutic challenge, due to their heterogeneity and limited treatment options. Conventional imaging techniques and therapeutic strategies may become unreliable during follow-up, due to...
2.
Pietroluongo E, Luciano A, Peddio A, Buonaiuto R, Caltavituro A, Servetto A, et al.
J Med Virol
. 2024 Aug;
96(8):e29849.
PMID: 39135451
Kaposi's sarcoma (KS) is an angio-proliferative disease with a viral etiology and a multifactorial pathogenesis that results from immune dysfunction. In patients affected by latent viral infections such as herpesviruses,...
3.
Luciano A, Pietroluongo E, Ottaviano M, Grieco A, Peddio A, De Placido P, et al.
Front Immunol
. 2024 Jul;
15:1423800.
PMID: 39026684
Thymic epithelial tumors are rare malignancies with an incidence of 1.7 cases per million people per year. They pose significant management challenges due to their association with autoimmune disorders. In...
4.
Pietroluongo E, Peddio A, De Placido P, Tortora M, Ottaviano M, Gelzo M, et al.
BMC Cancer
. 2024 Jun;
24(1):748.
PMID: 38898390
Introduction: Thymic epithelial tumors (TETs) are rare neoplasms often associated with immune-related disorders. Patients with Good's syndrome (GS), an adult-acquired TET-related immunodeficiency, are at a high risk of mortality due...
5.
Cernera G, Gelzo M, De Placido P, Pietroluongo E, Raia M, Scalia G, et al.
Clin Chem Lab Med
. 2024 Jan;
62(6):1198-1205.
PMID: 38232092
Objectives: Thymic epithelial tumors (TET) patients are at high risk of autoimmune and hypoimmune complications. Limited evidence is available on the potential risk of immune-related and inflammatory reactions induced by...
6.
Giordano C, Accattatis F, Gelsomino L, Del Console P, Gyorffy B, Giuliano M, et al.
Int J Mol Sci
. 2023 Nov;
24(21).
PMID: 37958677
Circulating extracellular vesicle (EV)-derived microRNAs (miRNAs) are now considered the next generation of cancer "theranostic" tools, with strong clinical relevance. Although their potential in breast cancer diagnosis has been widely...
7.
Cernera G, Gelzo M, De Placido P, Ottaviano M, Pietroluongo E, Raia M, et al.
Front Immunol
. 2023 Sep;
14:1233056.
PMID: 37705978
Background: Thymic epithelial tumors (TETs) are rare malignancies with heterogeneous clinical manifestations. The high frequency of autoimmune paraneoplastic disorders observed in such patients requires caution when using COVID-19 vaccines. Furthermore,...
8.
Pietroluongo E, De Placido P, Tortora M, Martinelli C, Viggiano A, Saponaro M, et al.
J Thorac Oncol
. 2023 Jun;
18(10):1399-1407.
PMID: 37390981
Introduction: Thymic epithelial tumors (TETs) are rare malignancies associated with dysregulation of the immune system and humoral- and cell-mediated immunity abnormalities. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine...
9.
Buonaiuto R, Neola G, Cecere S, Caltavituro A, Cefaliello A, Pietroluongo E, et al.
Biomolecules
. 2023 May;
13(4).
PMID: 37189400
Ovarian cancer (OC) is the leading cause of death from gynecological malignancies worldwide. Fortunately, recent advances in OC biology and the discovery of novel therapeutic targets have led to the...
10.
Caltavituro A, Buonaiuto R, Pietroluongo E, Morra R, Salomone F, De Placido P, et al.
Biomedicines
. 2023 Mar;
11(3).
PMID: 36979853
Sarcomas of the thoracic cavity are rare entities that predominantly affect children and young adults. They can be very heterogeneous encompassing several different histological entities. Ewing Sarcoma (ES) can potentially...